215 related articles for article (PubMed ID: 24607727)
1. Risk factors of sensitization to human leukocyte antigen in end-stage renal disease patients.
Hung SY; Lin TM; Chang MY; Wang HH; Lee YC; Ho LC; Chen YT; Hung CM; Liou HH
Hum Immunol; 2014 Jun; 75(6):531-5. PubMed ID: 24607727
[TBL] [Abstract][Full Text] [Related]
2. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
3. Independent of nephrectomy, weaning immunosuppression leads to late sensitization after kidney transplant failure.
Augustine JJ; Woodside KJ; Padiyar A; Sanchez EQ; Hricik DE; Schulak JA
Transplantation; 2012 Oct; 94(7):738-43. PubMed ID: 22955228
[TBL] [Abstract][Full Text] [Related]
4. De novo produced anti-human leukocyte antigen antibodies relation to alloimmunity in patients with chronic renal failure.
Pirim I; Soyoz M; Ayna TK; Kocyigit AO; Gurbuz BC; Tugmen C; Kurtulmus Y; Ozyilmaz B
Genet Test Mol Biomarkers; 2015 Jun; 19(6):335-8. PubMed ID: 25826018
[TBL] [Abstract][Full Text] [Related]
5. Anti-HLA antibody profile of Turkish patients with end-stage renal disease.
Karahan GE; Seyhun Y; Oguz F; Kekik C; Onal E; Caliskan Y; Bakkaloglu H; Yazici H; Turkmen A; Aydin AE; Sever MS; Eldegez U; Carin MN
Transplant Proc; 2009 Nov; 41(9):3651-4. PubMed ID: 19917361
[TBL] [Abstract][Full Text] [Related]
6. Harmful effect of preformed anti-MICA antibodies on renal allograft evolution in early posttransplantation period.
Sánchez-Zapardiel E; Castro-Panete MJ; Castillo-Rama M; Morales P; Lora-Pablos D; Valero-Hervás D; Ruiz-García R; Apaza J; Talayero P; Andrés A; Morales JM; Paz-Artal E
Transplantation; 2013 Jul; 96(1):70-8. PubMed ID: 23624543
[TBL] [Abstract][Full Text] [Related]
7. Effects of different sensitization events on HLA alloimmunization in solid organ transplantation patients.
Hyun J; Park KD; Yoo Y; Lee B; Han BY; Song EY; Park MH
Transplant Proc; 2012 Jan; 44(1):222-5. PubMed ID: 22310619
[TBL] [Abstract][Full Text] [Related]
8. Association of HLA phenotypes of end-stage renal disease patients preparing for first transplantation with anti-HLA antibody status.
Karahan GE; Kekik C; Oguz FS; Onal AE; Bakkaloğlu H; Calişkan YK; Yazici H; Turkmen A; Aydin AE; Sever MS; Eldegez U; Carin MN
Ren Fail; 2010 Jan; 32(3):380-3. PubMed ID: 20370456
[TBL] [Abstract][Full Text] [Related]
9. Potential risk factors for hypersensitization reflected by panel-reactive antibodies in dialysis patients.
Pour-Reza-Gholi F; Daneshvar S; Nafar M; Firouzan A; Farrokhi F; Einollahi B
Transplant Proc; 2005 Sep; 37(7):2936-8. PubMed ID: 16213266
[TBL] [Abstract][Full Text] [Related]
10. Effect of Single Sensitization Event on Human Leukocyte Antigen Alloimmunization in Kidney Transplant Candidates: A Single-Center Experience.
Resse M; Paolillo R; Pellegrino Minucci B; Costa D; Fiorito C; Santangelo M; De Rosa P; Napoli C
Exp Clin Transplant; 2018 Feb; 16(1):44-49. PubMed ID: 28661314
[TBL] [Abstract][Full Text] [Related]
11. Association Between HLA Antibodies and Different Sensitization Events in Renal Transplant Candidates.
Akgul SU; Ciftci HS; Temurhan S; Caliskan Y; Bayraktar A; Tefik T; Kaya IA; Canitez IO; Demir E; Yazici H; Bakkaloglu H; Aydin AE; Turkmen A; Nane I; Aydin F; Oguz FS
Transplant Proc; 2017 Apr; 49(3):425-429. PubMed ID: 28340805
[TBL] [Abstract][Full Text] [Related]
12. Duration of end-stage renal disease and kidney transplant outcome.
Goldfarb-Rumyantzev A; Hurdle JF; Scandling J; Wang Z; Baird B; Barenbaum L; Cheung AK
Nephrol Dial Transplant; 2005 Jan; 20(1):167-75. PubMed ID: 15546892
[TBL] [Abstract][Full Text] [Related]
13. Significance of panel reactive antibodies in patients requiring kidney transplantation.
Mishra MN; Baliga KV
Saudi J Kidney Dis Transpl; 2013 May; 24(3):495-9. PubMed ID: 23640620
[TBL] [Abstract][Full Text] [Related]
14. New law of renal transplantation in Portugal associated with more acute rejection episodes and higher costs.
Gonçalves JA; Jorge C; Atalaia A; Matias P; Bruges M; Birne R; Dickson J; Weigert A; Machado D
Transplant Proc; 2012 Oct; 44(8):2276-9. PubMed ID: 23026572
[TBL] [Abstract][Full Text] [Related]
15. HLA phenotypes of ESRD patients are risk factors in the panel-reactive antibody (PRA) response.
Heise E; Manning C; Thacker L
Clin Transplant; 2001; 15 Suppl 6():22-7. PubMed ID: 11903382
[TBL] [Abstract][Full Text] [Related]
16. A lifetime versus a graft life approach redefines the importance of HLA matching in kidney transplant patients.
Meier-Kriesche HU; Scornik JC; Susskind B; Rehman S; Schold JD
Transplantation; 2009 Jul; 88(1):23-9. PubMed ID: 19584676
[TBL] [Abstract][Full Text] [Related]
17. HLA and MICA allosensitization patterns among patients supported by ventricular assist devices.
Askar M; Hsich E; Reville P; Nowacki AS; Baldwin W; Bakdash S; Daghstani J; Zhang A; Klingman L; Smedira N; Moazami N; Taylor DO; Starling RC; Gonzalez-Stawinski G
J Heart Lung Transplant; 2013 Dec; 32(12):1241-8. PubMed ID: 24075503
[TBL] [Abstract][Full Text] [Related]
18. Panel reactive antibody positivity and associated HLA antibodies in Turkish renal transplant candidates.
Ozdemir FN; Sezer S; Akcay A; Arat Z; Turan M; Gulmus S; Kulah E; Haberal M
Transpl Immunol; 2004 Jan; 12(2):185-8. PubMed ID: 14967317
[TBL] [Abstract][Full Text] [Related]
19. Role of human leukocyte antigen, donor-specific antibodies, and their impact in renal transplantation.
Thiyagarajan UM; Bagul A; Frost J; Horsburgh T; Nicholson ML
Transplant Proc; 2012 Jun; 44(5):1231-5. PubMed ID: 22663991
[TBL] [Abstract][Full Text] [Related]
20. Panel reactive antibodies in predicting hepatitis C virus treatment outcome in kidney transplant candidates.
Öcal S; Harmancı Ö; Korkmaz M; Ensaroğlu F; Çolak T; Selçuk H; Moray G; Haberal M
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():193-6. PubMed ID: 25894153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
